type III secretion system-targeting therapy (Creative Antibiotics/Wisconsin University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nametype III secretion system-targeting therapy (Creative Antibiotics/Wisconsin University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPseudomonas InfectionsEscherichia coli Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin-Madison
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCreative Antibiotics Sweden ABUniversity Of Wisconsin-Madison
Active IndicationsN/A
Inactive IndicationsPseudomonas InfectionsEscherichia coli Infections

Other Information

ATC CodeN/A
Related LinksN/A